Profile

Dr. Jacqueline Houtman

Science Editorial Lead, The Pandemic Tracking Collective

Jacqueline Houtman’s doctoral research investigated the immune response to a coronavirus in a mouse model for multiple sclerosis. She participated in the Data Entry and Science Communication teams at The COVID Tracking Project at The Atlantic. As a freelance biomedical science writer and editor, she worked with organizations including the University of Wisconsin School of Medicine and Public Health, FASEB, The Dana Foundation, and The National Hemophilia Foundation. She is an award-winning author of books for young people.

Dr. Houtman received a BA in Biological Sciences and an MS in Animal Science from the University of Delaware, as well as a PhD in Medical Microbiology and Immunology from the University of Wisconsin-Madison.

Authored Content

  • Feb 16 2022
    Blueprint Tracking SARS-CoV-2 and Its Variants in Wastewater: An Old Technique Is Yielding Powerful New Insights in the Covid-19 Pandemic The newest addition to the Centers for Disease Control and Prevention’s (CDC) Covid Data Tracker reports on levels of SARS-CoV-2 RNA in wastewater. While researchers, public health departments, and some private companies have been monitoring wastewater since the beginning of the pandemic, this tracker marks an important step in the establishment of the National Wastewater Surveillance System […] Dave Luo, Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz, Megan Diamond
  • Dec 28 2021
    Field Note Vaccine Inequity Increases the Risk of New SARS-CoV-2 Variants Emerging Robust genomic surveillance, along with transparency, communication, and global collaboration, is needed to detect and control emerging variants. To control the Covid-19 pandemic, the World Health Organization (WHO) called on member states to meet a goal of vaccinating 40% of their population by the end of 2021. As of mid December 2021, over 8.6 billion […] Dave Luo, Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Jonathan Gilmour, Lindsey Shultz
  • Dec 01 2021
    Blog Post Genomic Surveillance Is Essential To Track Covid-19 Variants in Both Unvaccinated and Vaccinated Populations Technological advancements have made sequencing quicker and more affordable, but collaboration, outreach, and trust are needed to achieve representative samples from underserved populations. The course of the Covid-19 pandemic depends not only on how the SARS-CoV-2 virus changes, but on how communities respond to it. Public health officials can only make decisions to protect their […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
  • Nov 09 2021
    Blog Post The Critical Challenge of Tracking Breakthrough Infections, and Why We Still Need Better Data Standards Despite ample vaccine supplies, outbreaks among unvaccinated populations in the US and the appearance of the Delta variant promote infection in fully vaccinated individuals. These breakthrough infections must be carefully tracked. As the percentage of Americans considered fully vaccinated reached 58 percent, and Covid-19-related deaths surpassed three quarters of a million, concerns over breakthrough infections […] Dr. Rick Bright, Emily Bass, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
  • Jul 30 2021
    Blog Post Making Sense of Variants: They All Deserve Attention. A Few Merit Concern. SARS-CoV-2 has already mutated since it was first identified and will continue to do so. Robust global genomic sequencing is the best tool for tracking existing variants and detecting new ones. This information enables public health officials, governments, and communities to take action that can save lives. The more high-quality data that is available, the […] Dr. Rick Bright, Jacqueline Houtman, Jessica Malaty Rivera, Lindsey Shultz, Rebecca Glassman
Back to Top